Press Releases NEXGEL, Inc.

Equities

NXGL

US65344E1073

Delayed Nasdaq Other stock markets 09:48:12 2024-06-11 am EDT			5-day change	1st Jan Change
2.135 ^USD	-1.16%		+2.15%	+0.23%

May. 16	NEXGEL, Inc. acquired Silly George.	CI
May. 13	NEXGEL, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

NEXGEL and STADA Partner to Launch Leading European DAO Enzyme Supplement, Histasolv, in North America	08:40am	AQ
NEXGEL Acquires International Beauty Brand, Silly George	May. 16	AQ
NEXGEL Reports First Quarter 2024 Revenue of $1.27 Million, an Increase of 104% Year-Over-Year	May. 13	AQ
NEXGEL to Report First Quarter 2024 Financial Results on May 13th	May. 09	AQ
NEXGEL to Present at the Aegis Capital Virtual Conference on May 9, 2024	May. 06	AQ
NEXGEL to Present at the Planet MicroCap Showcase: VEGAS 2024, May 1 & 2, 2024	Apr. 18	AQ
NEXGEL Reports Full Year 2023 Revenue of $4.1 Million, an Increase of 99.7% Year-Over-Year	Apr. 01	AQ
NEXGEL Reschedules Fourth Quarter and Full Year 2023 Financial Results Conference Call to Monday, April 1st at 8:30 a.m. ET Due to Holiday	Mar. 27	AQ
NEXGEL to Report Fourth Quarter and Full Year 2023 Financial Results on March 28th	Mar. 21	AQ
NEXGEL to Present at the iAccess Alpha Best Ideas Spring Virtual Conference on March 12th	Mar. 04	AQ
NEXGEL Announces $975,000 Registered Direct Offering Led by Insiders	Feb. 21	AQ
NEXGEL to Present at The Microcap Conference, January 30th through February 1st	Jan. 18	AQ
NEXGEL Subsidiary, CG Converting and Packaging, Begins 12,000 Square Foot Expansion of Texas Facility to Support the Expected Growth in Product Demand in 2024	Jan. 09	AQ
NEXGEL Announces Partnership with STADA to Distribute and Commercialize Consumer Health OTC Products in North America	Dec. 11	AQ
NEXGEL Acquires Kenkoderm Psoriasis Skincare Line	Dec. 05	AQ
NEXGEL Reports Record Third Quarter 2023 Revenue of $1.2 Million, an Increase of 115% Year-Over-Year	Nov. 13	AQ
NEXGEL to Report Third Quarter 2023 Financial Results on November 13th	Nov. 02	AQ
NEXGEL Secures Supply Agreement with AbbVie	23-10-30	AQ
NEXGEL to Participate in the LD Micro Main Event XVI on October 3rd	23-09-26	AQ
NEXGEL Reports Second Quarter 2023 Record Revenue of $1.17 Million, an Increase of 108% Year-Over-Year	23-08-14	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases NEXGEL, Inc.

Equities

NXGL

US65344E1073

Press Releases

Filters